The availability of biosimilars commonly used to treat moderate to severe RA may not by itself reduce out-of-pocket costs for Medicare beneficiaries due to a lack of manufacturer discounts.
UCSF ranked sixth on the national Best Hospitals Honor Roll and received special recognition for exceptional performance in 15 medical specialties, including top-10 status in a dozen.
Researchers at UCSF are pioneering a new technique, known as quantitative magnetic resonance imaging, or qMRI, that can reveal the earliest signs of cartilage damage, a precursor to osteoarthritis.
UCSF's schools of Dentistry and Medicine have helped to craft a unified and definitive set of classification criteria for Sjögren's syndrome.
Exciting advances in medicine and health are being researched in precision medicine projects recently funded by the George and Judy Marcus Program in Precision Medicine Innovation.
The highest honor of the American College of Rheumatology has been awarded to David Wofsy, director of the Russell/Engleman Rheumatology Research Center at UCSF.
Ephraim Engleman, a pioneering rheumatologist whose passion and dedication to his work at UCSF spanned a staggering seven decades, has died at 104.
A research team led by scientists from UCSF, Baylor College of Medicine, and Texas Children’s Hospital has identified a new autoimmune syndrome characterized by a combination of severe lung disease and arthritis that currently has no therapy.
Scores of autoimmune diseases mysteriously cause the immune system to harm tissues within our own bodies. Now, a new study pinpoints the complex genetic origins for many of these diseases.
New pharmaceuticals to fight autoimmune diseases, such as multiple sclerosis, rheumatoid arthritis and psoriasis, may be identified more effectively by adding genome analysis to standard drug screening, according to a new study by a research team led by UC San Francisco and Harvard researchers.